As shared in a letter titled, “Implementation of first phase of Martha’s Rule” sent from NHS England to NHS trusts and foundation trusts issued today, Wednesday 21 February 2024, the Health Innovation Network has been confirmed as a delivery partner for implementing Martha’s Rule.

‘Martha’s Rule’, which gives patients and their families round-the-clock access to a rapid review from an independent critical care team if they are worried about their or a loved one’s condition, is named in memory of thirteen-year old Martha Mills.

Martha tragically died after developing sepsis in hospital due to a failure to escalate her to intensive care and after her family’s concerns about her deteriorating condition were not responded to promptly.

Extensive campaigning by her parents Merope and Paul, supported by the cross-party think tank Demos, has seen widespread support for a single system that allows patients or their families to trigger an urgent clinical review from a different team in the hospital if the patient’s condition is rapidly worsening and they feel they are not getting the care they need.

This national programme will build on NHS England’s Worry and Concern pilots launched at seven trusts last year, which developed and tested escalation methods for patients’ and families’ concerns.

Work to support the delivery of Martha’s Rule builds on the existing managing deterioration activity delivered by the Health Innovation Network’s 15 regionally-based Patient Safety Collaboratives (PSCs) to support the National Patient Safety Improvement Programme (NatPatSIP) – a key part of the NHS Patient Safety Strategy and commissioned through NHS England patient safety team.

Since 2019, PSCs have engaged with systems to support the implementation of deterioration tools in order to provide staff with the training and confidence to recognise and escalate concerns around physical deterioration in a number of settings such as acute hospitals, community, mental health, and ambulance trusts and more recently care homes across England. This work is part of the Managing Deterioration Safety Improvement Programme (ManDetSIP) and is part of a wider programme of work exploring a whole system and pathway approach to the management of deterioration.

NHS England will soon commence the process of recruiting the first 100 or more provider sites to take part in the first phase of Martha’s Rule implementation.

Cheryl Crocker, Health Innovation Network Patient Safety Director said:

“We welcome the introduction of Martha’s Rule. Patients and their loved ones play an important role in ensuring patient safety, and the national introduction of Martha’s Rule will help in ensuring these vital voices are heard.

“This new system, alongside many of the other processes and measures being rolled out to improve the identification and management of deterioration, will have a significant impact on the care patients receive.

“We look forward to supporting this vital work, alongside NHS England and providers from April.”

For more information on how we will be supporting the implementation of Martha’s Rule, email the Health Innovation Network team, or learn more about our managing deterioration work here.

 

  • Meet the innovator: Angie Doshani

    Angie Doshani, is founder of JanamApp and Consultant Obstetrician and Gynaecologist at University Hospitals of Leicester NHS Trust. JanamApp is a ground-breaking solution addressing the disparities in pregnancy outcomes faced by South Asian women, who experience a 1.8 times higher risk compared to their white counterparts. The challenges of some women from this demographic include [...]

  • Polypharmacy Action Learning Set celebrates 1000th delegate

    Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]

  • Meet the innovator: Jo Barosa, Qbtech

    Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]